Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -995.4% | -515.1% |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 14.4 | 16.1 |
Pr/Book | 1.4 |
Latest | F'cast | |
---|---|---|
Revenue | 110.0% | 32.7% |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | 0.58 | (9.04) | (4.61)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | 0.76 | (13.74) | (6.51)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 1.01 | (17.36) | (6.66)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 1.04 | (24.44) | (8.96)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 2.19 | (21.63) | (7.72)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-24 | 2.90 | (14.94) | (4.81)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-25 | 4.30 | (13.02) | (3.89)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 7.30 | (10.00) | (3.13)p | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Issue of LTIP Options and Share Options | 21-Mar-2025 | 07:00 | RNS |
Results of Eisai Phase 2 pilot study | 21-Mar-2025 | 07:00 | RNS |
Analysis of CTC-DNA and ctDNA using Illumina assay | 29-Jan-2025 | 07:00 | RNS |
Angle completes assay development projects | 21-Mar-2025 | ShareCast |
Angle's Parsortix system used in 'breakthrough' ... | 24-Jan-2025 | ShareCast |
Berenberg slashes target price on Angle | 23-Jan-2025 | ShareCast |
New Angle for Braveheart | 26-Jan-2009 | The Scotsman |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 9.75p |
Change Today | -0.75p |
% Change | -7.14 % |
52 Week High | 23.46 |
52 Week Low | 7.25 |
Volume | 1,676,971 |
Shares Issued | 322.64m |
Market Cap | £31.46m |
RiskGrade | 312 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
15:37 | 100,000 @ 9.67p |
15:17 | 5,010 @ 9.70p |
14:55 | 1,616 @ 9.67p |
14:46 | 4,700 @ 9.85p |
14:39 | 103,572 @ 9.66p |
CEO | Andrew D Newland |
Finance Director | Ian F Griffiths |
Chair | Jan Groen |
You are here: research